Results 101 to 110 of about 51,957 (233)

Promoting endothelial recovery and reducing neointimal hyperplasia using sequential-like release of acetylsalicylic acid and paclitaxel-loaded biodegradable stents

International Journal of Nanomedicine, 2014
Cheng-Hung Lee,1,2 Chia-Ying Yu,2 Shang-Hung Chang,1 Kuo-Chun Hung,1 Shih-Jung Liu,2 Chao-Jan Wang,3 Ming-Yi Hsu,3 I-Chang Hsieh,1 Wei-Jan Chen,1 Yu-Shien Ko,1 Ming-Shien Wen1 1Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial
Lee CH, Yu CY, Chang SH, Hung KC, Liu SJ, Wang CJ, Hsu MY, Hsieh IC, Chen WJ, Ko YS, Wen MS   +10 more
doaj  

Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review

BMC Pulmonary Medicine
Background Rapamycin has been extensively utilized for coating coronary artery stents to reduce the occurrence of restenosis, yet there has been limited research on the potential harms of rapamycin-eluting stents. Herein, We report a case of eosinophilia
Fuyun Zhang, Wei Wang, Yingwei Zhu, Yimin Mao, Tongsheng Wang, Pengfei Gao   +5 more
doaj   +1 more source

Drug-eluting Stents in Diabetic Patients [PDF]

, 2006
Julinda Mehilli, Gjin Ndrepepa
openalex   +1 more source

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program

Vascular Health and Risk Management, 2009
R Michael Kirchner, J Dawn AbbottDepartment of Cardiology, Rhode Island Hospital, Brown Medical School, Providence, RI, USAAbstract: Drug-eluting stents (DES) have had a major impact in interventional cardiology.
R Michael Kirchner, J Dawn Abbott
doaj  

Outcomes With Various Drug-Eluting or Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction [PDF]

, 2013
Sripal Bangalore, Nicholas Amoroso, Maria Fusaro, Sunil Kumar, Frederick Feit   +4 more
openalex   +1 more source

Drug-eluting Stents [PDF]

Der Chirurg, 2009
A. Martens, A. Haverich
openaire   +2 more sources

Two-year Outcome of Turkish Patients Treated with Zotarolimus Versus Paclitaxel Eluting Stents in an Unselected Population with Coronary Artery Disease in the Real World: A Prospective Non-randomized Registry in Southern Turkey

International Journal of Medical Sciences, 2011
Background: Our purpose was to investigate the clinical outcomes of Zotarolimus- and Paclitaxel-eluting stents in Turkish patients with coronary artery disease (CAD).
Davran Çiçek, Hasan Pekdemir, Cevahir Haberal, Nihat Kalay, Süleyman Binici, Hakan Altay, Haldun Müderrisoğlu
doaj  

Erhöhtes Risiko für Stentthrombosen bei DES? [PDF]

, 2018
Zusammenfassung: Im Vergleich zu unbeschichteten Stents ("bare-metal stents" [BMS]) verhindern medikamentenbeschichtete Stents ("drug-eluting stents" [DES]) mit großer Effektivität die Entstehung von Restenosen und damit die Notwendigkeit von ...
Kaiser, Christoph, Pfisterer, Matthias
core  

Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS]) [PDF]

, 2011
Young‐Guk Ko, Jung‐Sun Kim, Byeong‐Keuk Kim, Donghoon Choi, Myeong‐Ki Hong, Dong Woon Jeon, Joo-Young Yang, Young Keun Ahn, Myung Ho Jeong, Cheol Woong Yu, Kyeong Ho Yun, Do‐Sun Lim, Yangsoo Jang   +12 more
openalex   +1 more source

Characterisation of the mechanobiology of stents in vitro [PDF]

, 2014
This paper was presented at the 4th Micro and Nano Flows Conference (MNF2014), which was held at University College, London, UK. The conference was organised by Brunel University and supported by the Italian Union of Thermofluiddynamics, IPEM, the ...
4th Micro and Nano Flows Conference (MNF2014), Boldock, L, Casbolt, H, Cevans, P, Hsiao, S, Perrault, C, Poitevin, C   +6 more
core